Pyrimido [4, 5-D] azepine derivatives as 5-HT2C agonists

Details for Australian Patent Application No. 2008231543 (hide)

Owner Pfizer Limited

Inventors Andrews, Mark David; Whitlock, Gavin Alistair; Roberts, Lee Richard; Fish, Paul Vincent; Brennan, Paul Edward; Blagg, Julian; Storer, Robert Ian

Agent Spruson & Ferguson

Pub. Number AU-B-2008231543

PCT Pub. Number WO2008/117169

Priority 60/896,527 23.03.07 US

Filing date 14 March 2008

Wipo publication date 2 October 2008

Acceptance publication date 28 July 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/117169 Priority application(s): WO2008/117169

28 July 2011 Application Accepted

  Published as AU-B-2008231543

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231549-Novel benzamide derivatives as modulators of the follicle stimulating hormone

2008231532-Method and system for motion vector predictions